Cargando…

E2F1 germline copy number variations and melanoma susceptibility

BACKGROUND: Melanoma is an aggressive type of skin cancer whose aetiology remains elusive as both environmental and genetic factors can contribute to its development. Recent studies have demonstrated the existence of multiple copies of E2F1 gene in melanoma specimens which could explain the deregula...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocca, Maria Santa, Benna, Clara, Mocellin, Simone, Rossi, Carlo Riccardo, Msaki, Aichi, Di Nisio, Andrea, Opocher, Giuseppe, Foresta, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542053/
https://www.ncbi.nlm.nih.gov/pubmed/31142321
http://dx.doi.org/10.1186/s12967-019-1933-0
_version_ 1783422869930246144
author Rocca, Maria Santa
Benna, Clara
Mocellin, Simone
Rossi, Carlo Riccardo
Msaki, Aichi
Di Nisio, Andrea
Opocher, Giuseppe
Foresta, Carlo
author_facet Rocca, Maria Santa
Benna, Clara
Mocellin, Simone
Rossi, Carlo Riccardo
Msaki, Aichi
Di Nisio, Andrea
Opocher, Giuseppe
Foresta, Carlo
author_sort Rocca, Maria Santa
collection PubMed
description BACKGROUND: Melanoma is an aggressive type of skin cancer whose aetiology remains elusive as both environmental and genetic factors can contribute to its development. Recent studies have demonstrated the existence of multiple copies of E2F1 gene in melanoma specimens which could explain the deregulated E2F1 activity in this type of cancer. This finding suggests a key role for this transcription factor in the malignant transformation of melanocytes. Therefore, E2F1 has been considered as a potential therapeutic target for this form of skin cancer. Since germline copy number variations (CNVs) have been associated with increased susceptibility to different types of cancer, the aim of our study was to assess germline E2F1 CNV in melanoma patients. However, CNVs not necessarily lead to gene dosage imbalance, hence, further factors, in association with CNVs, could contribute to clinical manifestations. Considering that heat stress has been hypothesised as a contributing factor to skin cancer, we also investigated the effect of heat stress on E2F1 expression. METHODS: E2F1 CNV was measured in genomic DNA isolated from blood of 552 patients diagnosed with melanoma and 520 healthy subjects using TaqMan Copy Number Assays. E2F1 mRNA expression was also evaluated by RT-qPCR in the melanoma cell line, SK MEL 267, before and after exposure to heat stress. RESULTS: We found that patients diagnosed with melanoma (1.6%, 9/552) harboured frequently altered germline E2F1 copies compared to healthy subjects (0%, 0/520). Moreover, the difference among the two groups was statistically significant (p = 0.004). Furthermore, we found that heat exposure alone can significantly induce E2F1 expression. CONCLUSIONS: This is the first study that shows a relation between germline E2F1 CNV and melanoma, suggesting that altered copies of this gene might be a predisposing factor to skin cancer. Our results also suggest that environmental insults, such as heat stress, could contribute to an aberrant E2F1 activity by inducing E2F1 mRNA expression. Therefore, subjects with multiple constitutive copies of E2F1 are at greater risk of developing melanoma when exposed to heat. Altogether our results corroborate with the hypothesis that susceptibility to melanoma depends on both the environment and genetic factors.
format Online
Article
Text
id pubmed-6542053
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65420532019-06-03 E2F1 germline copy number variations and melanoma susceptibility Rocca, Maria Santa Benna, Clara Mocellin, Simone Rossi, Carlo Riccardo Msaki, Aichi Di Nisio, Andrea Opocher, Giuseppe Foresta, Carlo J Transl Med Research BACKGROUND: Melanoma is an aggressive type of skin cancer whose aetiology remains elusive as both environmental and genetic factors can contribute to its development. Recent studies have demonstrated the existence of multiple copies of E2F1 gene in melanoma specimens which could explain the deregulated E2F1 activity in this type of cancer. This finding suggests a key role for this transcription factor in the malignant transformation of melanocytes. Therefore, E2F1 has been considered as a potential therapeutic target for this form of skin cancer. Since germline copy number variations (CNVs) have been associated with increased susceptibility to different types of cancer, the aim of our study was to assess germline E2F1 CNV in melanoma patients. However, CNVs not necessarily lead to gene dosage imbalance, hence, further factors, in association with CNVs, could contribute to clinical manifestations. Considering that heat stress has been hypothesised as a contributing factor to skin cancer, we also investigated the effect of heat stress on E2F1 expression. METHODS: E2F1 CNV was measured in genomic DNA isolated from blood of 552 patients diagnosed with melanoma and 520 healthy subjects using TaqMan Copy Number Assays. E2F1 mRNA expression was also evaluated by RT-qPCR in the melanoma cell line, SK MEL 267, before and after exposure to heat stress. RESULTS: We found that patients diagnosed with melanoma (1.6%, 9/552) harboured frequently altered germline E2F1 copies compared to healthy subjects (0%, 0/520). Moreover, the difference among the two groups was statistically significant (p = 0.004). Furthermore, we found that heat exposure alone can significantly induce E2F1 expression. CONCLUSIONS: This is the first study that shows a relation between germline E2F1 CNV and melanoma, suggesting that altered copies of this gene might be a predisposing factor to skin cancer. Our results also suggest that environmental insults, such as heat stress, could contribute to an aberrant E2F1 activity by inducing E2F1 mRNA expression. Therefore, subjects with multiple constitutive copies of E2F1 are at greater risk of developing melanoma when exposed to heat. Altogether our results corroborate with the hypothesis that susceptibility to melanoma depends on both the environment and genetic factors. BioMed Central 2019-05-29 /pmc/articles/PMC6542053/ /pubmed/31142321 http://dx.doi.org/10.1186/s12967-019-1933-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Rocca, Maria Santa
Benna, Clara
Mocellin, Simone
Rossi, Carlo Riccardo
Msaki, Aichi
Di Nisio, Andrea
Opocher, Giuseppe
Foresta, Carlo
E2F1 germline copy number variations and melanoma susceptibility
title E2F1 germline copy number variations and melanoma susceptibility
title_full E2F1 germline copy number variations and melanoma susceptibility
title_fullStr E2F1 germline copy number variations and melanoma susceptibility
title_full_unstemmed E2F1 germline copy number variations and melanoma susceptibility
title_short E2F1 germline copy number variations and melanoma susceptibility
title_sort e2f1 germline copy number variations and melanoma susceptibility
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542053/
https://www.ncbi.nlm.nih.gov/pubmed/31142321
http://dx.doi.org/10.1186/s12967-019-1933-0
work_keys_str_mv AT roccamariasanta e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT bennaclara e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT mocellinsimone e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT rossicarloriccardo e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT msakiaichi e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT dinisioandrea e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT opochergiuseppe e2f1germlinecopynumbervariationsandmelanomasusceptibility
AT forestacarlo e2f1germlinecopynumbervariationsandmelanomasusceptibility